Although previous studies, such as Cui, reported downregulation of TPM2 in CRC cell lines, these findings were derived from in vitro models and may not fully capture the gene’s behavior in patient-derived tumor tissues (47). The gene discussed is TPM2; the disease is colorectal carcinoma.